lorlatinib
Search documents
Nuvectis Pharma (NasdaqCM:NVCT) Update / Briefing Transcript
2025-12-02 14:02
Nuvectis Pharma (NasdaqCM:NVCT) Update / Briefing December 02, 2025 08:00 AM ET Company ParticipantsAsier Unciti-Broceta - Professor of ChemistryRon Bentsur - Chairman, CEO and PresidentTara - Head of Investor RelationsAlexander Spira - Chief Scientific OfficerChristopher Liu - Managing DirectorConference Call ParticipantsAydin Huseynov - AnalystJoseph Pantginis - AnalystNaz Rahman - AnalystYale Jen - AnalystJonathan Aschoff - AnalystModeratorGreetings and welcome to the Nuvectis Pharma investor call to dis ...